Dr. Barry Hardy Hardy is currently leading Douglas Connect and its team supporting the development of new integrating solutions in industrial safety assessment. An example application is that for integrated testing for skin sensitization available at DouglasConnect. He has coordinated the OpenTox project in predictive toxicology and the ToxBank infrastructure development project. He is currently President of the OpenTox Association, founded in 2015 as an international non-profit organisation promoting an open knowledge community approach to new methods in predictive toxicology.
Johannes Kirchmair is Professor of Applied Bioinformatics at the Center for Bioinformatics, University of Hamburg, and Head of the Junior Research Group for Applied Cheminformatics and Molecular Design. He earned his PhD in Cheminformatics/Medicinal Chemistry from the University of Innsbruck in 2007. Johannes started his career as Application Scientist at Inte:Ligand, Vienna, and University Assistant at his Alma Mater.
Dr. Mukund Chorghade is a serial entrepreneur, President and Chief Scientific Officer, THINQ Pharma / THINQ Discovery, and of Chorghade Enterprises. He is the Chief Scientific Officer of Chicago Discovery Solutions, and has had Adjunct Research Professor / Visiting Fellow / Scientists appointments at Harvard, MIT, Princeton, Cambridge, Caltech, Univ. of Chicago, Northwestern, Strathclyde and several other universities. Dr. Chorghade earned his B. Sc. and M. Sc. degrees from the University of Poona, and a Ph. D. in organic chemistry at Georgetown University.
Philip Judson studied chemistry at the university of Manchester before working on the synthesis of novel herbicides and fungicides for Fisons Ltd at Chesterford Park Research Station near Saffron Walden. When computing started to come into use in chemistry he took an interest in knowledge-based computer systems and became Head of Chemical Information and Computing for Schering Agrochemicals Ltd.